Skip to main content

New Products: Jan 15, 2010


Proteome Software this week introduced its mass spectrometry quality control web-based tool, MassQC, to help researchers achieve more reproducible LC-MS/MS experiments.

The tool increases reproducibility by "examining repeated, standard runs for small numbers of known proteins, and covers both width and breadth of LC-MS system performance," Proteome Software said in a statement. It added that the tool reduces the amount of time researchers would spend evaluating the performance of their instruments.

A 30-day evaluation of MassQC is available here.

Proteome Solutions last week launched ProteinID Finder version 1.8.0.

The new version adds "new powerful graphing capabilities," which provide researchers better insight into their data, and allow "a quick and easy way to view their proteomics data," the company said in a statement. The software provides bar charts and Venn diagrams so that users can identify differences between protein lists.

New features include bar-chart and pie-chart displays for proteins identified in experiments; bar-chart and table displays of comparisons of experiments; the identification of relationships between experiments based on patterns and similarities using area proportional Venn diagrams; and the ability to export bar charts, pie charts, and Venn diagrams as images.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.